An official State of Texas website.
The Texas Pharmaceutical Initiative (TPI) was established through House Bill 4990 (88R).
The goal of the Initiative is to provide greater, and more cost-effective access to prescription drugs and essential medical supplies to employees, dependents, and retirees of public higher education systems, members of the Employees Retirement System of Texas (ERS), members of the Teacher Retirement System of Texas (TRS), individuals under the Texas Department of Criminal Justice or Texas Juvenile Justice Department, and individuals served by health and human services programs, including Medicaid and the Child Health Insurance Program.
TPI Business Plan
Pursuant to Tex. Gov’t Code Sec. 2177.006, TPI submitted its business plan to “the governor, the legislature, and the Legislative Budget Board” on September 30, 2024. You may utilize the following link to review the Business Plan for Texas Pharmaceutical Initiative (PDF) and the Business Plan for Texas Pharmaceutical initiative Footnotes (PDF) as submitted.
Members
- Mike McKinney, M.D., Chair, Bryan, TX
- Goldina Erowele, Pharm.D., Missouri City, TX
- Tony Schell, Austin, TX
Advisory Council Members
- MacGregor Stephenson, Director of Strategic Operations, Texas Health & Human Services
- Blaise Duran, Acting Director, Group Benefits Program, Employees Retirement System of Texas
- Katrina Daniel, Chief Health Care Officer, Teacher Retirement System of Texas
- Dr. John Zerwas, Executive Vice Chancellor for Health Affairs, The University of Texas System
- Sheri Meyer, Director, System Benefits Administration, Texas A&M University System
Meeting Dates
- February 9, 2024 (1 p.m.)
- March 7, 2024 (10 a.m.)
- April 9, 2024 (10 a.m.)
- May 9, 2024 (10 a.m.)
- June 11, 2024 (10 a.m.)
- July 16, 2024 (1 p.m.)
- August 8, 2024 (10 a.m.)
- August 20, 2024 (1 p.m.)
- September 5, 2024 (10 a.m.)
- September 23, 2024 (10 a.m.)
- December 4, 2024 (1 p.m.)